Baird Financial Group’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-109,682
| Closed | -$26.9M | – | 1793 |
|
|
2022
Q3 | $26.9M | Sell |
109,682
-1,439
| -1% | -$353K | 0.08% | 240 |
|
|
2022
Q2 | $27.5M | Buy |
111,121
+39,458
| +55% | +$9.77M | 0.08% | 254 |
|
|
2022
Q1 | $23.7M | Sell |
71,663
-36,421
| -34% | -$12.1M | 0.06% | 285 |
|
|
2021
Q4 | $38.8M | Sell |
108,084
-1,464
| -1% | -$526K | 0.09% | 214 |
|
|
2021
Q3 | $35.7M | Sell |
109,548
-8,115
| -7% | -$2.64M | 0.09% | 217 |
|
|
2021
Q2 | $36.7M | Buy |
117,663
+37,048
| +46% | +$11.6M | 0.1% | 215 |
|
|
2021
Q1 | $25.7M | Sell |
80,615
-36,557
| -31% | -$11.7M | 0.07% | 247 |
|
|
2020
Q4 | $38M | Buy |
117,172
+4,210
| +4% | +$1.36M | 0.11% | 209 |
|
|
2020
Q3 | $31.3M | Sell |
112,962
-12,716
| -10% | -$3.52M | 0.11% | 217 |
|
|
2020
Q2 | $30.4M | Sell |
125,678
-8,327
| -6% | -$2.01M | 0.11% | 204 |
|
|
2020
Q1 | $19.4M | Buy |
134,005
+97,006
| +262% | +$14M | 0.09% | 234 |
|
|
2019
Q4 | $6.32M | Sell |
36,999
-174,393
| -82% | -$29.8M | 0.02% | 482 |
|
|
2019
Q3 | $37.6M | Buy |
211,392
+5,418
| +3% | +$964K | 0.15% | 170 |
|
|
2019
Q2 | $53.7M | Buy |
205,974
+115,170
| +127% | +$30M | 0.21% | 125 |
|
|
2019
Q1 | $26M | Buy |
90,804
+5,104
| +6% | +$1.46M | 0.15% | 181 |
|
|
2018
Q4 | $27.9M | Buy |
85,700
+22,224
| +35% | +$7.22M | 0.19% | 146 |
|
|
2018
Q3 | $28.2M | Buy |
63,476
+51,999
| +453% | +$23.1M | 0.18% | 153 |
|
|
2018
Q2 | $4.7M | Buy |
11,477
+4,574
| +66% | +$1.87M | 0.03% | 450 |
|
|
2018
Q1 | $2.01M | Buy |
6,903
+4,492
| +186% | +$1.31M | 0.01% | 643 |
|
|
2017
Q4 | $452K | Buy |
2,411
+193
| +9% | +$36.2K | ﹤0.01% | 1041 |
|
|
2017
Q3 | $374K | Buy |
+2,218
| New | +$374K | ﹤0.01% | 1056 |
|
|
2016
Q4 | – | Sell |
-19,941
| Closed | -$2.56M | – | 1275 |
|
|
2016
Q3 | $2.56M | Buy |
+19,941
| New | +$2.56M | 0.02% | 499 |
|